Tiny Blue Dot

Tiny Blue Dot

Tiny Blue Dot was founded in 2018 by Andrew Chung, a former partner at Khosla Ventures where he led investments in renewable energy and sustainable technology. The firm emerged from Chung's conviction that climate change presents the largest re-industrialization opportunity of the century, requiring dedicated, science-first capital rather than opportunistic allocations from generalist funds. Tiny Blue Dot invests across the climate technology stack, targeting early-stage companies working on decarbonization, carbon removal, sustainable agriculture, and next-generation energy systems. The firm makes primarily Series A and B investments, though it has flexibility to engage at seed and growth stages when the science demands it. Known portfolio holdings include Commonwealth Fusion Systems, the MIT spinout pursuing commercial fusion energy, and Living Carbon, a biotechnology company engineering trees for enhanced carbon sequestration. The geographic footprint spans North America and Europe, with offices in Cambridge, Menlo Park, Santa Monica, London, and Greenwich that position the firm near key research universities and climate policy hubs. Since inception, Tiny Blue Dot has assembled a team of investors with backgrounds spanning venture capital, academic research, and policy — though the exact headcount remains undisclosed. The firm's multi-coastal US presence and London office support direct sourcing from university labs, government research programs, and climate accelerators. In 2023, Tiny Blue Dot participated in Commonwealth Fusion Systems' $2 billion Series B round, one of the largest private fusion investments on record (per Reuters, 2023). The firm operates through a traditional venture fund structure without adjacent philanthropic or operating vehicles, keeping capital deployment focused on venture-scale returns from deep technology. Tiny Blue Dot's structural distinction lies in its scientific advisory network — the firm draws on researchers and engineers from institutions including MIT, Stanford, and Caltech to diligence the technical feasibility of portfolio candidates before committing capital. This lab-to-term-sheet pipeline bypasses the pattern-recognition shortcuts common in software venture, requiring every investment to clear a physics or biology gate that generalist climate funds rarely maintain in-house.